eribulin mesylate
eisai
['eribulin', 'halaven', 'eisai']
 eisai presents results of post hoc analysis of eribulin mesylate (halaven) at the european society for medical oncology (esmo) congress 2022
Free Online Press Release Distribution Service For Business